Qiao Xin, Zhou Jing-Jing, Li De-Pei, Pan Hui-Lin
From the Center for Neuroscience and Pain Research, Department of Anesthesiology and Perioperative Medicine (X.Q., H.-L.P.), and Department of Critical Care (J.-J.Z., D.-P.L.), The University of Texas MD Anderson Cancer Center, Houston.
Hypertension. 2017 Jan;69(1):154-162. doi: 10.1161/HYPERTENSIONAHA.116.07947. Epub 2016 Oct 31.
The elevated sympathetic outflow associated with hypertension is maintained by increased N-methyl-d-aspartate receptor (NMDAR) activity in the paraventricular nucleus (PVN) of the hypothalamus. Synaptic NMDAR activity is tightly regulated by protein kinases, including the Src family of tyrosine kinases. We determined whether Src kinases play a role in increased NMDAR activity of PVN neurons projecting to the rostral ventrolateral medulla and in elevated sympathetic vasomotor tone in spontaneously hypertensive rats (SHRs). The Src protein level in the PVN was significantly greater in SHRs than in normotensive Wistar-Kyoto (WKY) rats and was not significantly altered by lowering blood pressure with celiac ganglionectomy in SHRs. Inhibition of Src kinase activity with 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine (PP2) completely normalized the higher amplitudes of evoked NMDAR-mediated excitatory postsynaptic currents and puff NMDA-elicited currents of rostral ventrolateral medulla-projecting PVN neurons in SHRs. PP2 treatment also attenuated the higher frequency of NMDAR-mediated miniature excitatory postsynaptic currents of these neurons in SHRs. However, PP2 had no effect on NMDAR-excitatory postsynaptic currents or miniature excitatory postsynaptic currents of rostral ventrolateral medulla-projecting PVN neurons in WKY rats. NMDAR activity increased by an Src-activating peptide was blocked by PP2 but not by inhibition of casein kinase 2. In addition, microinjection of PP2 into the PVN not only decreased lumbar sympathetic nerve discharges and blood pressure but also eliminated the inhibitory effect of the NMDAR antagonist on sympathetic nerve activity and blood pressure in SHRs. Collectively, our findings suggest that increased Src kinase activity potentiates presynaptic and postsynaptic NMDAR activity in the PVN and sympathetic vasomotor tone in hypertension.
与高血压相关的交感神经输出增加是由下丘脑室旁核(PVN)中N-甲基-D-天冬氨酸受体(NMDAR)活性增加所维持的。突触NMDAR活性受到包括酪氨酸激酶Src家族在内的蛋白激酶的严格调控。我们确定Src激酶是否在投射到延髓头端腹外侧的PVN神经元的NMDAR活性增加以及自发性高血压大鼠(SHR)的交感神经血管运动张力升高中发挥作用。SHR的PVN中Src蛋白水平显著高于正常血压的Wistar-Kyoto(WKY)大鼠,并且通过SHR的腹腔神经节切除术降低血压后,其Src蛋白水平没有显著改变。用4-氨基-5-(4-氯苯基)-7-(二甲基乙基)吡唑并[3,4-d]嘧啶(PP2)抑制Src激酶活性,可使SHR中投射到延髓头端腹外侧的PVN神经元诱发的NMDAR介导的兴奋性突触后电流和微量注射NMDA引发的电流的较高幅度完全恢复正常。PP2处理还减弱了SHR中这些神经元的NMDAR介导的微小兴奋性突触后电流的较高频率。然而,PP2对WKY大鼠中投射到延髓头端腹外侧的PVN神经元的NMDAR兴奋性突触后电流或微小兴奋性突触后电流没有影响。由Src激活肽增加的NMDAR活性被PP2阻断,但未被酪蛋白激酶2抑制所阻断。此外,向PVN中微量注射PP2不仅降低了腰交感神经放电和血压,还消除了NMDAR拮抗剂对SHR交感神经活动和血压的抑制作用。总的来说,我们的研究结果表明,Src激酶活性增加可增强PVN中的突触前和突触后NMDAR活性以及高血压中的交感神经血管运动张力。